The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Versant Vantage I, L.p. since year 2005.
The trader's CIK number is 1765253.
At the time of the last reporting, Versant Vantage I, L.p. was the 10% Owner of Black Diamond Therapeutics, Inc. .
(stock ticker symbol BDTX).
See this page for all insider trading activities at Black Diamond Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-03||BDTX||Black Diamond Therapeutics, Inc.||Buy||894,736||19.00||16,999,984|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Versant Vantage I, L.p. (10% Owner of Black Diamond Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.